Loading current evidence…
Public records only. Your private brief and follow-up notes are not included.
Ask what this evidence establishes, what remains open, or what to check next.
Reply from the General Administration of the National Medical Products Administration on Issues Relating to Changes in Manufacturing Sites by Marketing Authorisation Holders of Medicinal Products
药监综药注函〔2019〕237号 · 药监局综合司 · dated 2019-05-08, 2743 days ago
Found by citation: a local document that names this directive by its number or 《title》. One that restates it without naming it is not counted here. A citation shows the document names the directive, not that it carries all of it out, and a gap is not a finding of non-compliance.
The first held document from each province that cites the directive: from the provincial government, its departments, or a city or county. In the 6 provinces marked "full" we hold the provincial government's own document list (省政府 and its General Office), so a gap there is more telling; but a response can come from a department, be published outside that list, or name the directive without its number or title. Elsewhere "none found" may only mean we have not collected the document.
No held local document cites this directive yet.